Week in Washington
The FDA's latest proposed user fee structure for biosimilars will charge 10 percent of the new drug application fee, plus a development fee.
The U.S. Patent and Trademark Office and China's State Intellectual Property Office will expedite their patent examinations, which should allow applicants to obtain corresponding patents faster in each country.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter